Is Camurati-Engelmann disease hereditary?

Camurati-Engelmann disease is a hereditary genetic condition caused by mutations in the TGFB1 gene and follows an autosomal dominant inheritance pattern. This means an affected individual has a 50% chance of passing the mutation to each of their children, though cases can also arise from spontaneous, de novo mutations.

Is Camurati-Engelmann disease strictly hereditary?

Camurati-Engelmann disease, also known as progressive diaphyseal dysplasia, is a genetic disorder. In genetics, "hereditary" refers to a condition passed down through generations, while "genetic" refers to the underlying cause being a change in DNA. Camurati-Engelmann disease is both genetic and typically hereditary. It is caused by specific pathogenic variants in the TGFB1 (transforming growth factor beta-1) gene, which plays a crucial role in bone remodeling. While many individuals inherit Camurati-Engelmann disease from an affected parent, it is important to note that the condition can occasionally result from a de novo mutation, meaning the genetic change occurred spontaneously in the individual without either parent carrying the gene.

What is the inheritance pattern of Camurati-Engelmann disease?

Camurati-Engelmann disease follows an autosomal dominant inheritance pattern. Because of this, only one copy of the mutated TGFB1 gene is required to manifest the clinical features of the disease. When a parent has Camurati-Engelmann disease, the probability of transmitting the condition to their offspring is 50% for each pregnancy, regardless of the child's sex. Because the condition shows variable expressivity—meaning the severity of symptoms can differ significantly even among family members with the same mutation—a parent with mild symptoms may still pass the gene to a child who experiences more severe skeletal or muscular manifestations of Camurati-Engelmann disease.

How is genetic testing utilized for this condition?

Genetic testing is the definitive method for confirming a diagnosis of Camurati-Engelmann disease. Testing involves sequence analysis of the TGFB1 gene to identify pathogenic variants. Clinical geneticists generally recommend testing in the following scenarios:

• To confirm a diagnosis in a patient presenting with characteristic long-bone thickening (hyperostosis) and chronic pain.


• To provide clarity for family members who may be at risk but are currently asymptomatic.


• To assist with family planning and reproductive decision-making for those with a known family history.


• To differentiate Camurati-Engelmann disease from other skeletal dysplasias that may mimic its symptoms.

What is the role of genetic counseling for affected families?

Genetic counseling is a vital resource for the 107 members of the DiseaseMaps community and others living with Camurati-Engelmann disease. A genetic counselor provides essential support by calculating recurrence risks and explaining the implications of the TGFB1 mutation for future children. For families planning pregnancies, counselors can discuss options such as preimplantation genetic testing (PGT) or prenatal diagnosis via chorionic villus sampling (CVS) or amniocentesis. Beyond reproductive planning, counselors help families understand the variable nature of Camurati-Engelmann disease, ensuring that parents are prepared for the range of skeletal and systemic issues that may arise as their children grow.

Next steps

• Consult with a clinical geneticist or a metabolic bone specialist to discuss diagnostic testing for Camurati-Engelmann disease.


• Request a referral for formal genetic counseling to understand the specific risks for your extended family.


• Connect with the 107 members of the DiseaseMaps.org community to share experiences and coping strategies.


• Maintain regular orthopedic monitoring to manage the bone thickening and pain associated with the condition.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Camurati-Engelmann disease.


• Orphanet: Progressive diaphyseal dysplasia (ORPHA:1396).


• Online Mendelian Inheritance in Man (OMIM): Camurati-Engelmann disease (Entry #131300).